Average Co-Inventor Count = 5.85
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Allergan, Inc. (28 from 2,285 patents)
2. Bhat, Smita (0 patent)
3. Garst, Michael E. (0 patent)
4. Beard, Richard L. (0 patent)
5. Chow, Ken (0 patent)
6. Donello, John E. (0 patent)
7. Sinha, Santosh C. (0 patent)
28 patents:
1. 9079864 - Modulators of S1P receptors
2. 8993553 - Azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulators
3. 8815923 - Therapeutic compounds
4. 8809379 - Selective subtype alpha 2 adrenergic agents and methods for use thereof
5. 8735399 - Selective subtype alpha 2 adrenergic agents and methods for use thereof
6. 8735438 - Substituted-aryl-2-phenylethyl-1H-imidazole compounds as subtype selective modulators of alpha 2B and/or alpha 2C adrenergic receptors
7. 8541397 - Alkyne and alkene derivatives as sphingosine 1-phosphate-1 receptor modulators
8. 8530462 - Indole modulators of S1P receptors
9. 8492561 - Azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulators
10. 8486969 - Therapeutic compounds
11. 8431702 - Therapeutically useful substituted hydropyrido [3,2,1-ij] quinoline compounds
12. 8426454 - Therapeutic compounds
13. 8404663 - Alkyne and alkene derivatives as sphingosine 1-phosphate-1 receptor modulators
14. 8383646 - Therapeutic ((bicylicheteroaryl)imidazolyl) methylheteroaryl compounds
15. 8362022 - Selective subtype alpha 2 adrenergic agents and methods for use thereof